YOLT-202

N/A

Report date: 2026/03/16 13:39:32

Base Information

Drug NameYOLT-202
Drug Alias NameYOLT-202
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsGenetic Diseases, Inbornalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yaotang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRenji Hospital Affiliated To Shanghai Jiaotong University School Of MedicineShanghai Yaotang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inbornalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A